会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • PGP9.5 유전자 프로모터의 메틸화와 관련된 암 진단용조성물 및 그 용도
    • 用于检测与PGP9.5基因启动子甲基化相关的癌症的组合物及其用途
    • KR100852742B1
    • 2008-08-18
    • KR1020070016789
    • 2007-02-16
    • 경북대학교 산학협력단
    • 김동선김상걸
    • C12N15/13C12N15/09
    • A composition comprising non-methylated CpG islands of a PGP9.5 gene promoter is provided to be used to diagnose cancer since the methylation of the PGP9.5 gene influences on the expression of the PGP9.5 in cancer cells. A composition for diagnosing cancer such as gallbladder carcinoma, non-small cell lung cancer, invasive colorectal cancer and esophageal squamous cell carcinoma includes a polynucleotide sequence consisting of a sequence of SEQ ID : NO. 1, wherein bases from 131st to 329th of the SEQ ID : NO. 1 consist of non-methylated bases. A genetic marker for diagnosing the cancer consists of 198-496 numbers of a consecutive base sequence including the bases from 131st to 329th of the SEQ ID : NO. 1. A method for detecting methylation of a PGP9.5 gene promoter comprises the steps of: (a) obtaining a sample from an individual; (b) obtaining a genome DNA from the sample; (c) treating the genome DNA with a compound capable of deforming a cytosine base or a methylation sensitive restriction enzyme; (d) amplifying the treated DNA using a primer pair consisting of SEQ ID : NOs. 4 and 5 or 6 and 7 capable of amplifying CpG islands of the PGP9.5 gene promoter; and (e) identifying the existence of an amplified product. A kit for diagnosing the cancer comprises a primer for MSP(methylation specific PCR) consisting of a primer pair of SEQ ID : NOs. 4 and 5 as an effective ingredient.
    • 提供包含PGP9.5基因启动子的非甲基化CpG岛的组合物用于诊断癌症,因为PGP9.5基因的甲基化影响癌细胞中PGP9.5的表达。 用于诊断癌症的组合物,例如胆囊癌,非小细胞肺癌,侵袭性结肠直肠癌和食管鳞状细胞癌包括由SEQ ID NO:1所示的序列组成的多核苷酸序列。 1,其中SEQ ID NO:1的第131至329位的碱基。 1由非甲基化碱基组成。 用于诊断癌症的遗传标记物包括连续碱基序列的198-496个数目,包括SEQ ID NO:131的第131位至第329位的碱基。 1.一种检测PGP9.5基因启动子甲基化的方法,包括以下步骤:(a)从个体获得样品; (b)从样品中获得基因组DNA; (c)用能够使胞嘧啶碱基或甲基化敏感性限制酶变形的化合物处理基因组DNA; (d)使用由SEQ ID NO:构成的引物对扩增处理的DNA。 4和5或6和7能够扩增PGP9.5基因启动子的CpG岛; 和(e)鉴定扩增产物的存在。 用于诊断癌症的试剂盒包括由引物对SEQ ID NO:组成的用于MSP的引物(甲基化特异性PCR)。 4和5作为有效成分。